LINC01969: LINC01969 is an oncogene that promotes the migration, proliferation, invasion, and epithelial-mesenchymal transition (EMT) of ovarian cancer (OC) cells through the miR-144-5p/LARP1 axis [PMC7889973]. LINC01969 is highly expressed in OC tissues and cell lines [PMC7889973]. It is associated with lower overall survival in OC patients [PMC7889973]. LINC01969 knockdown decreases LARP1 expression and OC cell EMT in vivo [PMC7889973]. It also affects OC cell invasion and migration [PMC7889973]. LINC01969 acts as a ceRNA for miR-144-5p to control LARP1 expression and promote the proliferation, migration, and invasion of OC cells [PMC7889973]. The interaction between miR-144-5p and LINC01969 has been confirmed through RIP assay [PMC7889973]. Knockdown of LINC01969 increases E-cadherin expression but decreases Snail and Vimentin expression levels in OC cells [PMC7889973]. The role of LINC01969 as a prognostic biomarker for OC has been suggested based on its association with clinical stage and prognosis [PMC7889973]. The subcellular distribution of LINC01969 is mainly cytoplasmic but with some signal detected in the nucleus [PMC7889973]. In addition to its role in OC, lncRNA H19 promotes hepatocellular carcinoma bone metastasis by mediating PPP1CA/p38MAPK-dependent reduction in OPG expression [PMID: 33473219]